ABSTRACT
Celiac disease is an autoimmune disorder that develops after dietary exposure of the small intestine to gluten peptides in cereals. Celiac disease has a strong genetic component associated with HLA-DQ2 and HLA-DQ8, and testing for absence of these genetic markers is useful when serological tests and biopsies are indeterminate, as it renders celiac disease highly unlikely. We have developed a new real-time PCR assay, using sequence-specific primers (PCR-SSP) and TaqMan probes, for detection of DQB1*05, DQB1*02 (coding for DQ2) and DQB1*0302 (coding for DQ8). PCR amplification and detection of DQ2 and DQ8 was accurately and unambiguously performed from genomic DNA isolated from cell lines and human DNA. Amplification was scored digitally, without laboratory manipulation of amplified PCR products and with a higher accuracy than PCR-SSP. This assay should increase accuracy and throughput, and reduce risks of contamination in laboratories where testing for HLA DQ2 and DQ8 is performed as part of diagnosis of celiac disease.
Subject(s)
Celiac Disease/immunology , HLA-DQ Antigens/blood , Polymerase Chain Reaction/methods , Celiac Disease/blood , Celiac Disease/genetics , DNA/chemistry , DNA/genetics , DNA Primers/chemistry , DNA Primers/genetics , DNA Probes, HLA/chemistry , DNA Probes, HLA/genetics , HLA-DQ Antigens/genetics , HLA-DQ Antigens/immunology , HLA-DQ alpha-Chains , HLA-DQ beta-Chains , Humans , Sequence Analysis, DNAABSTRACT
HLA genotyping by polymerase chain reaction (PCR) has some inherent labor-intensive and effort-demanding limitations. To overcome them, we have developed a real-time PCR with hybridization probes approach able to obtain a medium-low resolution HLA-B genotyping with fewer tubes and probes and with a shorter time requirement. Our strategy used 18 simultaneous reactions amplifying HLA-B alleles and an internal control. Monitorization of both amplifications in each tube is performed by the simultaneous application of two fluorescent resonance emission transfer probes: the first probe, different for each tube, is specific for the HLA-B locus and the second probe detects the control gene. A medium-low resolution (300 HLA-B allelic groups) typing is obtained for each sample by analyzing the melting curve patterns. Because some alleles may be determined without using the complete set of reactions, we present an alternative strategy: a first round of seven reactions and, according to the result, a second (or third) round of PCRs to solve the ambiguities. This method was validated in pretyped clinical samples and the results were completely concordant. Moreover, fewer ambiguous results were obtained. In summary, we present a new, faster, and more accurate method than currently used PCR techniques to type HLA-B alleles.
Subject(s)
DNA Probes, HLA/genetics , Fluorescence Resonance Energy Transfer , Fluorescent Dyes , HLA-B Antigens/genetics , Polymerase Chain Reaction/methods , DNA/blood , DNA Probes, HLA/chemistry , Fluorescent Dyes/chemistry , Genotype , Humans , Time FactorsABSTRACT
We have developed a strategy for five-locus human leukocyte antigen (HLA) typing of hematopoeitic stem cell (HSC) donors using the polymerase chain reaction with sequence-specific primers (PCR-SSP). The PCR-SSP method is robust, reproducible, and accurate. New PCR-SSP mixtures can be added as required and all reactions are carried out under the same conditions, which can easily be applied to the typing of other loci, e.g., ABO blood groups. Initially, 127 PCR-SSP reactions were used to detect simultaneously HLA-A, -B, -C, -DRB1/3/4/5, and DQB1 alleles, differentiated generally to the level of the first two digits of the allele name, essentially equivalent to the serological split specificity. Approximately 40% of subjects were tested against a further 29 HLA-A, -B SSP mixtures to exclude rare alleles and unambiguously assign a two-digit HLA allele family. This gave an overall typing resolution equivalent to or greater than the split specificity level and covered all HLA-A, -B, -C, -DRBland DQB1 alleles listed in the WHO's Nomenclature for Factors of the HLA System, 2000. The Welsh Bone Marrow Donor Registry has used this strategy to HLA type over 35,000 HSC donors over 9 years. Comprehensive and accurate five-locus HLA typing allows confident and rapid identification of potential matched HSC donors for patients requiring stem cell transplantation generally without the need for typing additional loci. This allows resources to be focused directly on allele level typing of DRB1 and other loci. This strategy decreases overall donor work-up time, which is a major benefit to patients.
Subject(s)
DNA Probes, HLA/chemistry , Hematopoietic Stem Cell Transplantation , Histocompatibility Testing/methods , Polymerase Chain Reaction , Tissue Donors , Alleles , Base Sequence , DNA Primers , Female , Genotype , HLA Antigens/genetics , HLA-DR Antigens/genetics , HLA-DRB1 Chains , Humans , Male , Molecular Sequence Data , Sequence Analysis, DNA/methodsSubject(s)
B7-1 Antigen/biosynthesis , Elephantiasis, Filarial/immunology , Gene Expression Regulation , Animals , Antigens, CD/biosynthesis , Antigens, CD/blood , Antigens, CD/genetics , Antigens, Helminth/immunology , B7-1 Antigen/blood , B7-1 Antigen/genetics , B7-2 Antigen , Brugia malayi/genetics , Brugia malayi/immunology , DNA Primers/chemistry , DNA Probes, HLA/chemistry , Disease Models, Animal , Elephantiasis, Filarial/genetics , Elephantiasis, Filarial/parasitology , Leukocytes/parasitology , Macaca mulatta , Membrane Glycoproteins/biosynthesis , Membrane Glycoproteins/blood , Membrane Glycoproteins/genetics , Receptors, Antigen, T-Cell/immunology , Reverse Transcriptase Polymerase Chain ReactionABSTRACT
AIMS/BACKGROUND: Recent evidence suggests that spontaneous clearance of hepatitis C virus (HCV) may be associated with the HLA DQB1*0301 allele but there is still some debate over the role of other alleles and HLA haplotypes in HCV infection. As this may best be resolved by studying genetically different populations, we have investigated HLA class II-encoded susceptibility and resistance to HCV infection in a relatively sedentary population of patients from northwestern Poland. METHODS: The distributions of HLA class II DRB1, DQA1, DQB1 and DPB1 alleles were determined by standard PCR-protocol in 129 unrelated patients with chronic hepatitis C (anti-HCV and HCV-RNA positive) and 103 healthy unrelated racially-matched control subjects. Fifty-five patients were treated with alpha-interferon (5 MIU thrice weekly for 6 months) out of whom 29 showed a complete response and 26 were non-responders. RESULTS: A significantly reduced frequency of the DQB1*0301 allele in the patients was observed (24.0% vs. 38.8%; p=0.015). Additionally, two different DR-DQ haplotypes were found to be associated with chronic HCV infection: DRB1*1501-DQA1*01-DQB1*0602 (24.0% vs. 12.6%; p= 0.027) and DRB1*0701-DQA1*0201-DQB1*02 (31.8 vs. 12.6%; p=0.0006), the latter difference being most pronounced in those patients who responded to alpha-interferon treatment (41.4% vs. 12.6%; p=0.00048). CONCLUSIONS: The results confirm the negative association between chronic HCV and DQB1*0301 and identify two novel genetic associations. In particular, the DRB1*0701-DQA1*0201-DQB1*02 haplotype is associated with both chronic infection and response to alpha-interferon. Interestingly, the same haplotype is reportedly associated with non-response to hepatitis B vaccination.
Subject(s)
Genes, MHC Class II , HLA-DR Antigens/genetics , Haplotypes , Hepatitis C, Chronic/drug therapy , Hepatitis C, Chronic/immunology , Interferon-alpha/therapeutic use , Adult , Aged , DNA/analysis , DNA Probes, HLA/chemistry , Female , Gene Frequency , Genetic Predisposition to Disease , Hepacivirus/drug effects , Hepacivirus/isolation & purification , Hepatitis C Antigens/blood , Hepatitis C, Chronic/virology , Histocompatibility , Humans , Immunity, Innate/genetics , Male , Middle Aged , Poland , Polymerase Chain Reaction , Treatment OutcomeABSTRACT
The major histocompatibility complex (MHC) region was examined as a set of candidate genes for association between DNA markers and antibody response. Intercross F2 families of chickens were generated from a cross between high (HC) and low (LC) Escherichia coli(i) antibody lines. Restriction fragment length polymorphism (RFLP) analysis was conducted by using three MHC-related cDNA probes: chicken MHC class IV (B-G), chicken MHC class I (B-F), and human MHC-linked Tap2. Association between RFLP bands and three antibody response traits (E. coli, sheep red blood cells and Newcastle disease virus) were determined by two methods: by statistically analyzing each band separately and also by analyzing all bands obtained from the three probes by using multiple regression analysis to account for the multiple comparisons. The MHC class IV probe was the highest in polymorphisms but had the lowest number of bands associated with antibody response. The MHC class I probe yielded 15 polymorphic bands of which four exhibited association with antibody response traits. The Tap2 probe yielded 20 different RFLP bands of which five were associated with antibody production. Some Tap2 bands were associated with multiple antibody response traits. The multiband analysis of the three probes' bands revealed more significant effects than the analysis of each band separately. This study illustrates the efficacy of using multiple MHC region probes as candidate markers for quantitative trait loci (QTLs) controlling antibody response in chickens.
Subject(s)
Chickens/genetics , DNA Probes, HLA/chemistry , Genes, MHC Class I/genetics , Genetic Variation/genetics , Animals , Antibodies, Bacterial/biosynthesis , Antibodies, Viral/biosynthesis , Chickens/immunology , Crosses, Genetic , Enzyme-Linked Immunosorbent Assay/veterinary , Escherichia coli/immunology , Escherichia coli Infections/prevention & control , Escherichia coli Infections/veterinary , Female , Genes, MHC Class I/immunology , Hemagglutination Tests/veterinary , Male , Meat , Newcastle Disease/prevention & control , Newcastle disease virus/immunology , Polymorphism, Restriction Fragment Length , Quantitative Trait, Heritable , Regression Analysis , Vaccination/veterinaryABSTRACT
To confirm the significant association of sarcoidosis with HLA-DR5, -DR6, and -DR8 associated DRB1 alleles, in sarcoidosis patients from the eastern Japan (Kanto) area found in our previous study, we used HLA class II genotyping of patients in another region-Hokkaido, in northern Japan. The annual incidence of sarcoidosis in Hokkaido is about three times that of eastern Japan, and Hokkaido has one of the world's highest incidences of this disease. For the HLA class II (HLA-DRB1, -DRB3, -DQA1, -DQB1) genotyping, we used the polymerase chain reaction restriction fragment polymorphism (PCR-RFLP) method with 150 subjects: 40 sarcoidosis patients and 110 healthy controls. The frequencies of DRB1*12, DRB1*14, DRB1*08, DQA1*0501, and DQB1*0301 were significantly increased in the patients, compared with the controls. Our finding of a high frequency of DRB1*08 (which lacks the DRB3 gene encoding the DR52 antigen) in patients living in both eastern Japan and in Hokkaido, confirms that it is the HLA-DRB1 locus, rather than that of the HLA-DRB3, -DQA1, or -DQB1, which determines the susceptibility to sarcoidosis.